pyrrolidonecarboxylic acid has been researched along with Kidney Diseases in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Keceli, G; Lindsey, ML; Paolocci, N; Sourdon, J | 1 |
Bac, P; Dartevelle, P; El Tawil, Z; German-Fattal, M; Hulin, A; Lecerf, F; Maurois, P; Sabbagh, F | 1 |
Jang, KY; Jang, YB; Kang, KP; Kim, DH; Kim, W; Lee, JE; Lee, S; Lee, SY; Moon, SO; Park, SK; Sung, MJ | 1 |
Al Moundhri, MS; Ali, BH; Nemmar, A; Tag Eldin, M; Tanira, MO | 1 |
Bailie, MB; Hook, JB; Newton, JF; Smith, JH | 1 |
Antener, I; Mollica, F; Pavone, L | 1 |
6 other study(ies) available for pyrrolidonecarboxylic acid and Kidney Diseases
Article | Year |
---|---|
Death of an antioxidant brings heart failure with preserved ejection fraction to life: 5-oxoproline and post-ischaemic cardio-renal dysfunction.
Topics: Animals; Antioxidants; Disease Models, Animal; Fibrosis; Heart Failure; Kidney Diseases; Mice; Oxidative Stress; Pyrrolidonecarboxylic Acid; Stroke Volume | 2018 |
Impact of cyclosporine A on magnesium homeostasis: clinical observation in lung transplant recipients and experimental study in mice.
Topics: Administration, Oral; Adolescent; Adult; Animals; Creatinine; Cyclosporine; Dietary Supplements; Disease Models, Animal; Female; Homeostasis; Humans; Immunosuppressive Agents; Kidney Diseases; Lung Transplantation; Magnesium; Magnesium Deficiency; Male; Mice; Mice, Inbred C57BL; Middle Aged; Pyrrolidonecarboxylic Acid; Retrospective Studies; Time Factors; Treatment Failure | 2008 |
Protective role of L-2-oxothiazolidine-4-carboxylic acid in cisplatin-induced renal injury.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antigens, Differentiation; Antioxidants; Apoptosis; Caspase 3; Cell Line; Chemokine CCL2; Cisplatin; Cystine; Drug Evaluation, Preclinical; Gene Expression Regulation; Glutathione; Humans; Intercellular Adhesion Molecule-1; Kidney; Kidney Diseases; Kidney Function Tests; Kidney Tubules, Proximal; Macrophages; Male; Mice; Mice, Inbred C57BL; Oxidative Stress; Prodrugs; Protein Transport; Pyroglutamate Hydrolase; Pyrrolidonecarboxylic Acid; Superoxide Dismutase; Thiazolidines; Transcription Factor RelA | 2006 |
The ameliorative effect of cysteine prodrug L-2-oxothiazolidine-4-carboxylic acid on cisplatin-induced nephrotoxicity in rats.
Topics: Acetylglucosaminidase; Administration, Oral; Animals; Antineoplastic Agents; Antioxidants; Cisplatin; Creatinine; Glutathione; Kidney Cortex; Kidney Diseases; Male; Osmolar Concentration; Prodrugs; Pyrrolidonecarboxylic Acid; Random Allocation; Rats; Rats, Wistar; Superoxide Dismutase; Thiazolidines; Urea | 2007 |
Mechanism of chloroform nephrotoxicity. IV. Phenobarbital potentiation of in vitro chloroform metabolism and toxicity in rabbit kidneys.
Topics: Animals; Chloroform; Cytochrome P-450 Enzyme System; Drug Synergism; Enzyme Induction; In Vitro Techniques; Kidney; Kidney Cortex; Kidney Diseases; Male; Microsomes; p-Aminohippuric Acid; Phenobarbital; Phosgene; Pyrrolidonecarboxylic Acid; Rabbits; Tetraethylammonium; Tetraethylammonium Compounds; Thiazoles; Thiazolidines | 1984 |
Familial hyperprolinemia without mental retardation and hereditary nephropathy.
Topics: Amino Acid Metabolism, Inborn Errors; Epilepsy; Female; Glycine; Humans; Infant; Intellectual Disability; Kidney Diseases; Male; Proline; Pyrrolidonecarboxylic Acid | 1972 |